Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

GB Group Ord Shs GBGPF

Healthcare Technology Drug Manufacturers - Specialty & Generic Software - Application Cannabis
GB Group plc is a United Kingdom-based company, which provides identity data intelligence products and services helping organizations recognize and verify all elements of an individual's identity at key interactions in their business processes. The Company's segments include location, identity and fraud. The location segment includes address lookup, verification and capture; e-mail validation; phone verification, and data maintenance services. The identity segment includes document verification, data verification and identity investigation services. Its identity verification solutions can be configured to carry out a wide range of functions, including know your customer checks, anti-money laundering checks, age verification checks and liveness detection. The fraud segment includes transaction fraud monitoring, combating origination fraud and in-life fraud investigation services. It provides artificial intelligence powered screening for automatic onboarding or referral of customers.


OTCPK:GBGPF - Post by User

GB Group Ord Shs > Acb @ 6.22...The Bottom
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by StayInCashon Feb 02, 2018 11:38pm
83 Views
Post# 27495287

RE:RE:Acb @ 6.22...The Bottom

RE:RE:Acb @ 6.22...The BottomIf I was a gambler, I would bet Aphria or Canopy would make an offer for Cannimed.   Since the deal is not closed and competitive offer provisions are in the Offer and Agreement of Support.

Cannimed seems to have been a pure play medical cannabis stock that ignored the recreational market potential.  As an initial glance, that seems to be what is causing the current price mismatch with ACB? That's the only reason CMED's  assets are valued so low by the markets. 

Just $645M as market cap makes no sense? Compared to all the others it stands out as incredible value?  I can see why Aurora made a bid for it!

Am I reading this right?  I need to spend some time reviewing all the documents in detail!
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities